> Historical snapshot from 23 October 2026. Superseded by [the 26 October engineering report](COMPLETION_2026-10-26.md).

Dear Professor,

Thank you for sharing the research and the engineering workflow. I reviewed the publication and checked the existing NSO AI-PC V2.2 implementation.

I have added a V3 research workspace to the existing codebase. It includes longitudinal per-eye observations, transparent progression baselines, measured follow-up evaluation, frozen intervention-cohort reports, and an optical-optimizer job interface. A synthetic demonstration is available for reviewing the workflow. The implementation preserves the existing clinical fitting and manufacturing/QC functions and adds research-specific access controls and audit records.

The published model has not been reproduced or clinically validated for NSO. The current forecasts are research baselines, and individual treatment-effect estimates remain unavailable. Optical optimization is explicitly blocked until a simulator calibrated against measured lens and QC data is supplied. V3.1 adaptive ranking also remains unavailable pending prospective data and independent validation.

The local software integration has been tested. Production rollout remains pending deployment review. To advance to validated research models, we will need approved de-identified longitudinal AL/SE data, complete treatment exposure records, a locked study/validation plan, and the calibrated optical simulator and manufacturing constraints.

The accompanying implementation review maps the requested requirements to the completed software and the remaining clinical, data and optical dependencies.

Best regards,
Bryan
